Details for New Drug Application (NDA): 020833
✉ Email this page to a colleague
The generic ingredient in FLOVENT DISKUS 50 is fluticasone propionate. There are twenty-nine drug master file entries for this compound. Seventy-two suppliers are listed for this compound. Additional details are available on the fluticasone propionate profile page.
Summary for 020833
Tradename: | FLOVENT DISKUS 50 |
Applicant: | Glaxo Grp Ltd |
Ingredient: | fluticasone propionate |
Patents: | 0 |
Pharmacology for NDA: 020833
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 020833
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FLOVENT DISKUS 100 | fluticasone propionate | POWDER;INHALATION | 020833 | NDA | GlaxoSmithKline LLC | 0173-0600 | 0173-0600-02 | 1 INHALER in 1 CARTON (0173-0600-02) / 60 POWDER, METERED in 1 INHALER |
FLOVENT DISKUS 100 | fluticasone propionate | POWDER;INHALATION | 020833 | NDA | GlaxoSmithKline LLC | 0173-0601 | 0173-0601-02 | 1 INHALER in 1 CARTON (0173-0601-02) / 60 POWDER, METERED in 1 INHALER |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INHALATION | Strength | 0.05MG/INH | ||||
Approval Date: | Sep 29, 2000 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INHALATION | Strength | 0.1MG/INH | ||||
Approval Date: | Sep 29, 2000 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INHALATION | Strength | 0.25MG/INH | ||||
Approval Date: | Sep 29, 2000 | TE: | RLD: | Yes |
Expired US Patents for NDA 020833
Complete Access Available with Subscription